Related Experiment Video

Updated: Jan 4, 2026

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models
08:44

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models

Published on: November 11, 2014

8.4K

Strategy to selectively remove mutant proteins could combat neurodegeneration

Huda Y Zoghbi

    Nature
    |November 7, 2019
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    Drug discoveryNeurodegeneration

    More Related Videos

    Assays for the Degradation of Misfolded Proteins in Cells
    10:56

    Assays for the Degradation of Misfolded Proteins in Cells

    Published on: August 28, 2016

    12.4K
    Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
    14:55

    Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

    Published on: May 12, 2013

    61.6K

    Related Experiment Videos

    Last Updated: Jan 4, 2026

    Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models
    08:44

    Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models

    Published on: November 11, 2014

    8.4K
    Assays for the Degradation of Misfolded Proteins in Cells
    10:56

    Assays for the Degradation of Misfolded Proteins in Cells

    Published on: August 28, 2016

    12.4K
    Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
    14:55

    Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

    Published on: May 12, 2013

    61.6K

    Related Concept Videos

    In-vitro Mutagenesis01:16

    In-vitro Mutagenesis

    15.9K
    To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
    15.9K
    The Proteasome02:18

    The Proteasome

    10.0K
    Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
    In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
    10.0K
    The Proteasome01:13

    The Proteasome

    1.5K
    Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
    In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
    1.5K

    Articles linked to this work by shared authors, journal, and citation graph.

    Selective loss of primary cilia and neurotrophic signaling in G51D α-synuclein mice highlights a common pathway to Parkinson's disease.

    Proceedings of the National Academy of Sciences of the United States of America·2026

    Translational reading frame predicts the pathogenicity of C-terminal frameshift deletions in MeCP2.

    eLife·2026

    Functional divergence of Capicua isoforms explains differential tissue vulnerability in neurological disease.

    Genes & development·2026

    Single-nucleus profiling reveals a core disease signature and cell type-specific vulnerabilities in early Rett syndrome.

    Science advances·2026

    Astrocytic ACSBG1 depletion improves lipid-cytokine signaling and attenuates α-Synuclein pathology in a Parkinson's disease mouse model.

    bioRxiv : the preprint server for biology·2026

    Transcriptomic data and biomedical literature synergize in finding pharmacologic gene regulators.

    bioRxiv : the preprint server for biology·2026

    RFC1 Repeat Expansions in Chronic Idiopathic Axonal Polyneuropathy: Prevalence, Phenotype, and Diagnostic Implications.

    Journal of the peripheral nervous system : JPNS·2026

    Network Analysis in Central Disorders of Hypersomnolence: Insight Into Relationships Between Symptoms, Mental Health, and Quality of Life.

    Journal of sleep research·2026

    Association between sarcopenia and inflammation in non-geriatric patients with chronic kidney disease: a comparison of hemodialysis and non-hemodialysis patients.

    Journal of nephrology·2026

    Transmission ratio distortion of NF1 mutant alleles in familial Neurofibromatosis type 1.

    Genetics in medicine : official journal of the American College of Medical Genetics·2026

    Disease-Specific Glycopattern Signatures of Serum Small Extracellular Vesicles in Depression, Schizophrenia, and Glioblastoma.

    Proteomics·2026

    Blended Hereditary Neuropathy Phenotype Caused by Biallelic PRX and SCN9A Variants: A Case Report.

    Molecular syndromology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us